FDA Panel Calls for Better Labeling on Contact Lens Solutions

FDA's ophthalmic devices advisory panel is recommending stronger labeling on contact lens solutions and more thorough testing of them, the Associated Press reports. This move comes in light of two recalls of contact lens solutions -- one made by Bausch & Lomb and the other by Advanced Medical Optics -- that were linked to eye infections.

June 11, 2008

1 Min Read
FDA Panel Calls for Better Labeling on Contact Lens Solutions

The new labeling should include warnings not to reuse cleaning solution and recommendations to observe discard dates on lenses and to replace lens cases frequently, the panel said. It also suggested expanding the list of bacteria and fungi that lens solutions must be tested against before FDA can approve them. For example, Acanthamoeba keratitis, the eye-infecting parasite that AMO's solution was linked to, is not currently on the testing list.More on this topic will appear in the August issue of MD&DI.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like